Talking therapy may boost emotional awareness in bipolar patients
NCT ID NCT06721858
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether emotion-focused therapy (EFT) can improve mood awareness and reduce emotional reactivity in people with bipolar disorder. Fifty patients in remission took part, with half receiving six sessions of EFT plus standard care. The goal was to see if this therapy helps patients recognize and manage their emotions better, which could improve treatment adherence and daily functioning.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Emotion-focused therapy (psychotherapy)
- What this could lead to
- If it works, this could point toward a practical therapy to help people with bipolar disorder better understand and manage their emotions, potentially improving treatment adherence and quality of life.
- What could go wrong
- This is a small, completed study with only 50 participants, so results may not apply to everyone. The therapy is short-term and effects may fade over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Inclusion criteria are being between the ages of 18-65, 2. Being diagnosed with Bipolar Disorder (I, II) and receiving maintenance treatment and being in remission, 3. Receiving standard drug treatment (mood stabilizer, antipsychotic or antidepressant) and standard clinical follow-up for bipolar disorder, 4. Not having hearing, comprehension and vision problems, 5. Being able to read and write, 6. Being patients who agree to participate in the study. Exclusion Criteria: 1. Having another psychotic disorder in addition to the diagnosis of bipolar disorder, 2. Being newly diagnosed with bipolar disorder and being in the acute phase, 3. Wanting to leave the study, 4. Not agreeing to participate in the study,
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Therapy, directly observed are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Muğla Eğitim Ve Araştırma Hastanesi
Multiple Locations, Muğla, 48000, Turkey (Türkiye)